Isoniazid-induced alopecia in isoniazid-monoresistant pulmonary tuberculosis

Alopecia is a notable adverse effect linked to isoniazid treatment for tuberculosis, complicating patient care.
In a cohort of individuals with isoniazid-monoresistant tuberculosis, 30% experienced alopecia during treatment.
Observational analysis highlighting the side effects of isoniazid therapy in patients with pulmonary tuberculosis.
Findings may enable healthcare providers to adjust treatment plans to mitigate hair loss in affected individuals.

Cite This Study